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Several bacterial pathogens have TIR domain-containing proteins that contribute to their
pathogenesis. We identified a second TIR-containing protein in Brucella spp. that we have
designated BtpB. We show it is a potent inhibitor of TLR signaling, probably via MyD88.
BtpB is a novel Brucella effector that is translocated into host cells and interferes with
activation of dendritic cells. In vivo mouse studies revealed that BtpB is contributing to
virulence and control of local inflammatory responses with relevance in the establishment
of chronic brucellosis. Together, our results show that BtpB is a novel Brucella effector that
plays a major role in the modulation of host innate immune response during infection.
Keywords: Brucella, TIR domain, Btp1/BtpA, TLR, DC, NF-κB
INTRODUCTION
Innate immune recognition of microbial components is critical
for the onset of an appropriate immune response against invad-
ing pathogens. Key contributors include the toll-like receptor
(TLR)/IL-1R superfamily characterized by the presence of a con-
served region designated TIR domain located in the cytosolic part
of each TLR. The TIR domain is critical for protein-protein inter-
actions between TLRs with the corresponding TIR-containing
adaptors, which couple downstream protein kinases. This signal-
ing cascade ultimately leads to activation of specific transcription
factors such as nuclear factor-κB (NF-κB) and production of
inflammatory mediators. Although a variety of TLR receptors
have been described, in humans the most relevant for recognition
of bacterial molecules are TLR2, TLR4, TLR5, and TLR9.
In addition to TLRs and their adaptors, TIR domains are
present in plant resistance proteins that mediate hypersensi-
tive responses to pathogens, as well as in a variety of bac-
teria, including species present in the human gut microbiota,
soil bacteria and human pathogens (Spear et al., 2009; Zhang
et al., 2011). Their evolutionary history is complex and their
role in interaction with eukaryotic hosts remains mostly unchar-
acterized. Nevertheless, in a number of bacterial pathogens,
bacterial TIR-containing proteins have been implicated in viru-
lence or control of cellular responses. Salmonella enterica serovar
Enteritidis TlpA is capable of reducing NF-κB activation by TLR4,
IL-1R andMyD88-dependent pathways and to contribute to con-
trol of IL-1β secretion during infection (Newman et al., 2006).
In the case of uropathogenic E. coli CFT073, the TIR-containing
protein TcpC is able to interfere with TLR4 and TLR2 signal-
ing by targeting MyD88 (Cirl et al., 2008) but also to inhibit
TRIF- and IL-6/IL-1 dependent pathways (Yadav et al., 2010).
During infection, TcpC is implicated in the control of secre-
tion of TNF-α and IL-6 and tcpC mutants show a defect in
intracellular replication in a mouse model of pyelonephritis.
The Yersinia pestis TIR-containing protein YpTdp interacts with
MyD88 to reduce IL-1β- and LPS-dependent signaling and to
contribute to modulation of cytokine secretion during infection
(Spear et al., 2012).
In the case of Brucella spp. two groups independently reported
on the role of a TIR domain containing protein in control of TLR
signaling (Cirl et al., 2008; Salcedo et al., 2008). Naming of this
protein as Btp1 or TcpB, respectively, by two distinct laboratories
has led to some confusion in the literature and has been misinter-
preted by some as two independent proteins. Since neither Btp1
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nor TcpB conforms to the international guidelines for bacterial
nomenclature we will hereafter designate Btp1/TcpB as BtpA.
BtpA is present in B. abortus 2308 (BAB1_0279), B. abortus
9-941 (BruAb1_0274) and B. melitensis 16M (BMEI1674) but
is absent from B. suis 1330. Cirl et al. described that ectopically
expressed BtpA cloned from B. melitensis 16M is able to inter-
fere with TLR4 and TLR2 signaling by directly interacting with
MyD88. Several reports have proposed that BtpA targets the adap-
tor protein MAL/TIRAP (Radhakrishnan et al., 2009; Sengupta
et al., 2010). Direct comparison of the in vitro interaction between
BtpA and either MyD88 or TIRAP shows a stronger interaction
with MyD88 (Chaudhary et al., 2011). BtpA has been shown to
bind phosphoinositides at the plasmamembrane (Radhakrishnan
et al., 2009) but also to induce ubiquitination of TIRAP (Sengupta
et al., 2010). In accordance to its modulation of TLR function,
previous work from our laboratory described the role of the BtpA
from B. abortus in the control of dendritic cell (DC) activation
during infection (Salcedo et al., 2008). Purified BtpA was also
shown to inhibit CD8+ T cell-mediated killing suggesting it may
also control adaptive immune responses (Durward et al., 2012).
Here we present a novel Brucella effector with a TIR domain
that we designated as BtpB. We show that BtpB efficiently
inhibits TLR signaling and contributes to control of DC activa-
tion. Together, Brucella TIR-containing proteins BtpA and BtpB
modulate host inflammatory responses during infection.
RESULTS
IDENTIFICATION OF A SECOND Brucella TIR DOMAIN-CONTAINING
PROTEIN
Analysis of the Brucella genome revealed the presence of a second
TIR domain-containing protein (BAB1_0756) that we have des-
ignated BtpB (Figure 1A). We choose to continue with the Btp
nomenclature to avoid any confusion with the tcpB gene neces-
sary for conjugative transfer in Clostridium perfringens (Parsons
et al., 2007). Search for conserved domains in BtpB revealed the
presence of a C terminal TIR domain (aa 144-256) that belongs
to the Pfam family TIR_2 (E value 1.9 e−11), a family of bac-
terial Toll-like receptors. TIR domains share conserved motifs
called box 1 (F/Y-DAFISY), box2 (GYKLC-RD-PG) and box 3 (W
residue surrounded by basic amino acids). Sequence comparison
of BtpB TIR domain with the human TIR-containing proteins
MAL, MyD88, TLR2 and TLR4 showed sequence similarity and
conservation of box 1, essential for signaling (Rana et al., 2013)
(Figure 1A).
Unlike BtpA, BtpB is present in all sequenced Brucella
strains, including B. suis 1330 (BR0735), B. abortus 2308
(BAB1_0756), B. abortus 9-941 (BruAb1_0752) and B. meliten-
sis 16M (BME1216). Alignment of the btpB sequences derived
from different Brucella strains revealed 4 different annotations
for the start codon (highlighted in red in Figure 1B). Analysis of
the −18 to +18 nucleotides around the ATG/GTG (Kolaskar and
Reddy, 1985) predicted as the most likely start codon the second
methionine highlighted in Figure 1B. This open reading frame
has been annotated for B. abortus 9-941 and encodes a 292 amino
acid protein, BtpB (1-292). The additional annotated start codons
include the first highlighted methionine, the valine (GTG) and
the B. melitensis methionine resulting in proteins of either 325,
277 or 178 amino acids. None of them scored high enough to
be considered as likely start codons. Comparison of all Brucella
sequences available revealed only one BtpB (1-178), in B. meliten-
sis 16M, whereas the majority correspond to BtpB (1-292). In
consequence, we decided to use in this study the BtpB (1-292).
We first investigated the ability of BtpB to interfere with TLR
signaling using an in vitro NF-κB-dependent luciferase reporter
system. BtpB was able to inhibit TLR2, TLR4 and TLR9 signal-
ing (Figure 2A) even more efficiently than BtpA (Salcedo et al.,
2008). This inhibition was independent on the first 114 amino
acids as both BtpB (1-178) (Figure 2A), as well as, BtpB (1-292)
(Figure 2B) strongly inhibited TLR signaling. BtpB was also able
to inhibit flagellin-induced TLR5 signaling (Figure 2B). These
results suggest that BtpB may interfere with a common molecule
of these TLR pathways, such as MyD88. Consistently, BtpB did
not reduce TLR3-dependent signaling which does not involve the
adaptorMyD88 (Figure 2C). In addition, we observed by directed
yeast two-hybrid that BtpB was able to interact with MyD88
(Figure 2D). BtpA was also able to interact with MyD88 by
yeast-two hybrid as previously shown by pull-down and protein-
fragment complementation assays (Cirl et al., 2008; Chaudhary
et al., 2011). Neither BtpA nor BtpB interacted with any of the
TLR1 to TLR10 TIR domains nor with the adaptors TIRAP or
TRAM. As BtpA was previously shown to reduce TLR2 and TLR4
signaling but not TLR9 (Cirl et al., 2008; Salcedo et al., 2008)
we investigated its ability to interfere with TLR5, which is also
dependent onMyD88. BtpA was able to significantly reduce TLR5
signaling, following stimulation with S. typhimurium flagellin
(Figure 2E).
Overall, our results show that BtpB is a potent inhibitor of TLR
signaling in vitro, which may result from binding to MyD88.
BtpB IS TRANSLOCATED INTO HOST CELLS
In order for BtpA and BtpB to target TLR pathways they would
have to be exported across the bacterial membranes and the vac-
uolar membrane into the host cell cytosol. To test this hypothesis
we analysed the translocation of BtpA and BtpB fused at their N-
terminus with the TEM-1 β-lactamase during infection of RAW
macrophage-like cells. This method has been successfully used to
establish translocation of several Brucella effectors, namely VceA,
VceC and RicA (de Jong et al., 2008; de Barsy et al., 2011) and
is traditionally carried out in live cells. RAW cells were used in
order to achieve high rates of infection. VceC and VceA were
included as positive controls. We could detect BtpA translocation
into host cells at 4 h and 24 h after inoculation (Figures 3A,B).
Translocated BtpB was detected in less than 0.5% of infected cells
at 4 h and did not significantly increase at 24 h. In an attempt to
try to enhance the sensitivity of this assay, we carried out the same
experiments in fixed samples with observation of FRET within
15min of fixation, which enhances the shift to 450 nm (Nothelfer
et al., 2011). As in live cells, BtpA and to a lower extent BtpB were
translocated into host cells at 24 h after infection (Figures 3C,D).
Since the overall percentage of cells showing translocated effectors
is very low with this assay, even following fixation, we analysed
translocation of BtpA and BtpB fused to the adenylate cyclase
CyaA (Figure 3E). In addition, we used a constitutive promoter of
B. abortus bcsp31 gene to enhance expression, since this alternative
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FIGURE 1 | Identification of BtpB. (A) Identification of BtpB as bacterial
member of TLR/IL-1R (TIR) family. Comparison of the predicted amino acid
sequences of the TIR domain of BtpB with BtpA and the human members of
the TIR family: MAL, MyD88, TLR2 and TLR4. The alignment was
constructed with T-Coffee::advanced server from EMBnet
(http://www.ch.embnet.org) and coloring scheme corresponds to standard
ClustalX in which each residue in the alignment is assigned a color if the
amino acid profile at each position meets a minimum criteria specific for the
residue type. Box 1 corresponds to the signature sequence of the TLR family.
(B) Alignment of BtpB amino acid sequences for B. abortus 2308
(BAB1_0756), B. suis 1330 (BR0735), B. abortus 9-941 (BruAb1_0752) and
B. melitensis 16M (BME1216). The annotated starting codons
(Methionine/Valine) are highlighted in red. Amino acid differences are shaded
in red.
approach was successfully used with the Brucella effector protein
BPE123 (Marchesini et al., 2011), which was included as a positive
control in our experiments. In this system, any value of cAMP bel-
low 1500–2000 fmol/ml corresponds to background (dotted line
in Figure 3E) and is not indicative of translocation as determined
after performing an exhaustive screening for the identification
of Brucella abortus type IV secretion system (T4SS) substrates
(Marchesini et al., 2011). We found that at 4 h after infection both
BtpA and BtpB were translocated into J774.A1 macrophage-like
cells (Figure 3E). Interestingly, translocation of BtpA fused with
the CyaA seems to depend on the position of the tag as only BtpA
with C-terminal CyaA was efficiently translocated into host cells
at early stages of the infection. In contrast, for BtpB, the pres-
ence of the CyaA tag on the C-terminus reduced translocation
(Figure 3E).
To determine if the translocation of BtpA and BtpB was depen-
dent on the Brucella VirB T4SS, cells were infected with the
virB mutant carrying either TEM- or CyaA-fused Btp proteins.
We could not detect any differences between wild type and virB
mutant using the TEM-1 β-lactamase assay (Figures 3A–D). In
sharp contrast, translocation of BtpA-CyaA and CyaA-BtpB was
clearly reduced in a virB genetic background, indicating that
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FIGURE 2 | BtpB interferes with TLR signaling. (A) HEK293 cells were
transiently transfected for 24h with the luciferase reporter vector and either
TLR2, TLR4 and TLR9, in the presence or the absence of the 178 amino acid
BtpB (50ng). Cells were then stimulated with the appropriate ligand (PAM,
LPS and CpG) for 6 h before measurement of luciferase activity. White bars
correspond to negative control, black bars to cells stimulated with the
appropriate ligand and grey bars to cells transfected with BtpB and
stimulated with the ligand. Data represent the means ± standard errors of
relative luciferase activity obtained from triplicates of a representative
experiment. (B) Luciferase activity in the presence or absence of the BtpB
(1-292) (red bars). TLR5 was also included and stimulated with Flagellin from
S. typhimurium (Fl-ST) and (C) TLR3 following stimulation with poly(I:C).
(D) Yeast containing Gal4 BD- and Gal4 AD-fusion proteins were selected on
synthetic medium lacking leucine (Leu) and tryptophan (Trp) (left panel).
Protein interactions were identified on synthetic medium lacking histidine
(His) and supplemented with 20mM 3AT (middle panel). Growth on this
medium indicates interaction between fusion proteins. The blue yeast
colonies observed in the β-galactosidase expression filter assay indicate
interaction between the fusion proteins (right panel). BD and AD indicate
empty vectors and were used as negative controls, while MyD88
homodimerization was used as positive control. (E) Luciferase activity in cells
transfected with TLR5 in the absence or presence of 100 ng and 50ng of
BtpA (275 aa). P ≤ 0.001 are denoted with ∗∗∗; P ≤ 0.01 are denoted with ∗∗
and P between 0.01 and 0.05 are denoted with ∗ .
delivery of both proteins is dependent on the T4SS. We con-
clude that BtpA and BtpB are translocated into host cells and may
constitute substrates for the VirB T4SS.
BtpB REPLICATIONWITHIN MURINE BONE MARROW-DERIVED DCs
To determine the role of BtpB during infection we infected
murine bonemarrow-derived DCswith wild type Brucella, as well
as, with a btpA, btpB or btpAbtpB mutant strains. No attenuation
was observed as the btpAbtpB replicated to equivalent levels of the
wild type B. abortus strain (Figure 4A). The survival curves for
the single mutants overlap with that of the wild type (Figure 4A,
right panel).
As previously described for BtpA, murine DCs infected with
the btpB mutant showed higher level of MHC class II surface
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FIGURE 3 | BtpB is translocated into host cells during infection. (A) RAW
macrophages were infected with wild type (wt) or virB9 B. abortus strains
carrying N-terminal TEM-1 fused VceA, VceC, BtpA, and BtpB for 4 h and
24h. Data represents the means ± standard errors of the percentage of cells
with coumarin fluorescence from 5 independent experiments.
(B) Representative confocal images of RAW cells infected with either
wilt-type B. abortus (wt) or virB9 mutant carrying TEM-fused BtpA, at 24h
after inoculation. Appearance of blue cells is indicative of translocated TEM
lactamase. (C) and (D) Analysis of TEM-1 translocation assay for fixed
samples of VceA, VceC, BtpA, and BtpB 24h after infection. (E) Intracellular
cAMP levels in J774.A1 cells infected for 4 h with isogenic strains with a
functional (wt) or non-functional VirB system (virB10) expressing Btp proteins
fused to CyaA. Non-infected cells and a wild type strain expressing the CyaA
domain alone (pCyaA) were included as negative controls. A wild type strain
expressing BPE123-CyaA was included as a positive control. Means and SD
are shown for one representative out of three independent experiments.
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FIGURE 4 | Role of BtpB in control of DC activation. (A) BMDCs
infected with wild type B. abortus or the btpAbtpB mutant (left panel) and
the single mutants (right panel) were lysed and intracellular CFUs
enumerated at different times after inoculation. (B) Representative images
of BMDCs infected with either the wild type, btpB or btpAbtpB mutants
for 24h. Cells were labeled for MHC class II (red) and surface expression
is of a representative area is shown in zoom inlets. (C) Quantification of
the percentage of DCs containing DALIS after 24h of infection with wild
type B. abortus (wt), btpB− or btpAbtpB mutant. (D) Flow cytometry of
the surface expression of MHC class II, CD40, CD80 and CD86 at 24h
post-infection. Data are normalized to wt values. (E) Analysis of TNF-α and
(F) IL-12 (p40/p70) secretion measured by ELISA from the supernatant of
DCs 24h after inoculation. All the results correspond to the means ±
standard errors of 4 independent experiments. P ≤ 0.001 are denoted with
∗∗∗; P ≤ 0.01 are denoted with ∗∗ and P between 0.01 and 0.05 are
denoted with ∗ .
expression and higher percentage of formation of aggresome-
like induced structures (DALIS) that transiently appear during
the process of activation of these immune cells (Figures 4B,C)
(Lelouard et al., 2002). However, there was no additive effect of
depletion of both btpA and btpB as the btpAbtpB mutant did not
show an increased phenotype compared to single mutant.
Flow cytometry analysis of infected cells did not reveal a sta-
tistically significant increase in CD40, CD80 and CD86 surface
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expression in DCs infected with btpB mutant when compared
to the wild type at 8 h post-infection. At 24 h post-infection
there was a significant increase in MHC class II surface expres-
sion in DCs infected with btpB mutant relative to those infected
with the wild type (Figure 4D, white bars) consistent with our
microscopy observations (Figure 4B). In the case of DCs infected
with btpAbtpB mutant, CD40 and CD80 co-stimulation markers
were up-regulated (Figure 4D, black bars).
In terms of cytokine secretion, BtpB did not seem to be
involved in the control of TNF-α secretion during infection
of murine DCs (Figure 4E). The increase in TNF-α secretion
observed for btpAbtpB is probably due to a lack of BtpA, pre-
viously shown to be involved in the control of secretion of this
cytokine (Salcedo et al., 2008). However, an increase in the level
of total IL-12 (p40/p70) secreted during infection was observed in
the case of the btpB mutant compared to the wild type 24 h after
infection (Figure 4F). The difference between btpB and btpAbtpB
mutants is not significant. These results suggest that BtpB is
contributing to the control of the inflammatory response induced
in infected DCs in vitro.
BtpB CONTROLS NF-κB TRANSLOCATION IN DCs
In order to analyse the effect of the BtpB effector on the early
stages of DC activation, translocation of NF-κBwas monitored by
immunofluorescence microscopy during the course of the infec-
tion. As early as 2 h post-infection, bone marrow-derived DCs
infected with the btpB mutant showed an increased translocation
of NF-κB into the nucleus compared to those infected with wild
type B. abortus (Figure 5). The btpB mutant phenotype was res-
cued by expression of BtpB from a plasmid confirming the role of
BtpB in the control of NF-κB translocation into the nucleus.
These results confirm that BtpB has an effect on the induction
of inflammatory responses during Brucella infection.
ROLE OF BtpB IN THE MOUSE MODEL OF BRUCELLOSIS
To further investigate the role of BtpB during infection we carried
out in vivo studies. BtpA B. melitensis mutants were previously
shown to have enhanced survival in immuno-compromised
Interferon Regulatory Factor-1 (IRF-1)−/− mice (Radhakrishnan
et al., 2009) inoculated intra-peritoneally (i.p.), a lethality model
that has been used for studying Brucella virulence (Ko et al.,
FIGURE 5 | Modulation of NF-κB translocation to the nucleus during
Brucella infection. Bone marrow-derived DCs were infected with wild
type (wt) B. abortus, btpA, btpB and btpAbtpB mutants as well as
btpB mutant carrying the complementing plasmid (pbtpB) for 2 h and
processed for immunofluorescence confocal microscopy. Cells were
labeled for CD11c (cyan) and p65 NF-κB (red). Bacteria were labeled
with anti-LPS antibody followed by FITC secondary and nuclei with
TOPRO3. Salmonella infected cells were used as a positive control. (A)
Data corresponds to means ± standard errors of 4 independent
experiments. (B) Representative images obtained by confocal
microscopy are shown for DCs infected with wild type, btpB mutant,
btpBpbtpB complemented strain and btpAbtpB mutant. Scale bars
correspond to 5μm. P ≤ 0.001 are denoted with ∗∗∗; P ≤ 0.01 are
denoted with ∗∗ and P between 0.01 and 0.05 are denoted with ∗.
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2002). We therefore, inoculated IRF−/− i.p. with either btpA, btpB
or btpAbtpB B. abortus mutants. Although the btpB mutant had
no defect in intracellular replication in cultured cells in vitro,
it showed an attenuation phenotype in IRF-1−/− mice. Mice
infected with the btpBmutant survived longer than those infected
with the wild type B. abortus and synergistic effect was observed
for the double btpAbtpB mutant (Figure 6A, P < 0.005), despite
equivalent bacterial CFU counts in the spleen at each sampling
date after infection (median of 1.05 × 108 CFU/spleen for wild
type versus 6.5 × 107 CFU/spleen for the btpAbtpB mutant). To
better study the role of BtpB in brucellosis in vivo, we inocu-
lated wild type BALB/c mice i.p. and enumerated the bacterial
load at 30, 60, 90, and 130 days post-infection. No signifi-
cant differences in bacterial CFU counts between the wild type
Brucella and the btp mutants were observed at different stages
of the infection (30, 60, 90, and 130 days). Data at 60 days
post-infection is shown as an example (Figure 6B). We then
performed histological examination of spleens obtained from
wild type BALB/c mice infected with the btpA, btpB, btpAbtpB
mutants or the wild type B. abortus strains to quantify granu-
loma formation, which usually reflects the host’s ability to develop
a protective immune response. No granuloma was seen in the
spleen of non-infected mice. In infected mice, granulomas were
detected in splenic red pulp. A significantly higher number of
granulomas was observed following btpB and btpAbtpB infection
(after 60 days) compared to the wild type Brucella (Figure 6C).
Inflammatory granulomas showed a similar organization in
all populations of infected mice and were composed mainly
of macrophages and a few lymphocytes (Figure 6D). Bacteria
were detected by immunohistochemistry in the spleen of mice
infected with wild type B. abortus or with the btpAbtpB mutant
(Figure 6E). They were seen as coarse granular immune-positive
FIGURE 6 | Role of BtpB during Brucella infection in the mouse model
of brucellosis. (A) Susceptibility of IRF-1−/− to B. abortus 2308 (wt),
btpA−, btpB− and btpAbtpB mutant (n = 9 per group). Infected mice were
monitored daily for survival. Mice infected with btpB and tpAbtpB−
survived longer than wild type Brucella infected mice (P = 0.0433 and
P = 0.0152, respectively). (B) Persistence of B. abortus 2308 (wt), btpA,
btpB or btpAbtpB mutants in spleens of wild type BALB/c infected mice at
60 days p.i. Each symbol represents an animal and the median values are
marked by horizontal bold lines. (C) Analysis of granuloma formation in the
spleens of wild type BALB/c mice infected for 60 days with wild type
B. abortus, btpA, btpB or btpAbtpB mutants. Data represent means ±
standard deviations of 4 or 5 mice. (D) Representative image from the
spleen of a mouse infected with btpAbtpB mutant (hematoxylin-eosin,
original magnification ×400). (E) Bacteria were revealed by immunostaining
in the spleen of wild type BALB/c mice infected by btpAbtpB mutant of
B. abortus. Macrophages present in inflammatory granulomas in the red
pulp are packed with coarse immunopositive material (hemalun
counterstain, original magnification ×400). P ≤ 0.01 are denoted with ∗∗.
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material associated with cells, which had the morphology of
macrophages.
These results are consistent with a role for BtpB in the control
of inflammatory response during Brucella infection in vivo.
DISCUSSION
Previous work from our laboratory demonstrated a role for BtpA
in control of DC activation. Here we show that Brucella contains
a second TIR-domain protein called BtpB that is translocated into
host cells and which participates in the control of the inflamma-
tory response during Brucella infection. In vitro, BtpB is a potent
inhibitor of TLR2, TLR4, TLR5 and TLR9. Together with BtpA,
BtpB contributes to the control of DC activation during infection.
Using the TEM-1 lactamase and CyaA assays we were able
to detect BtpA and BtpB translocated into the cytosol as early
as 4 h after infection of RAW and J774 macrophages. This is an
essential step to enable BtpA and BtpB to cross the bacterial and
vacuolar membranes to reach their host cellular targets during
infection. It would be interesting to localize the translocated pro-
teins during infection. We have not been able to detect neither
2HA- nor 3FLAG-tagged BtpA and BtpB by immunofluores-
cence microscopy. It is possible that the amounts of translocated
BtpA and BtpB are too low or perhaps these proteins are quickly
degraded once they reach the host cytosol. It is important to note
that using the TEM-1 lactamase assay alone we were unable to
detect translocation of BtpB and any differences between wild
type and virB mutant in BtpA translocation. It is possible that
the low sensitivity of the TEM-1 lactamase compared to the
CyaA assay makes this methodology inappropriate to assess VirB
dependency in the case of effectors translocated at low levels. We
conclude from our results that BtpA and BtpB are likely substrates
of the VirB T4SS.
In this study, we found that B. abortus lacking btpA and
btpAbtpBmutants showed an increased survival time in the IRF-1
−/− mouse model, highlighting the importance of these TIR-
containing proteins in virulence. Similar results were obtained for
B. melitensis lacking BtpA, which is defective in systemic spread at
early stages of infection (Radhakrishnan et al., 2009). However,
the use of such a severely immune-compromised mouse model
hampers detailed analysis of the role of these proteins in control
of inflammatory responses during infection. Therefore, we pro-
ceeded with our in vivo studies using immune-competent mice.
We found that absence of BtpA and/or BtpB leads to increased
granuloma formation in wild type mice, probably restricting
bacterial dissemination as a consequence of the inability of the
mutants to modulate the inflammatory response.
Infection of DCs with B. abortus lacking BtpB revealed that
this effector protein is contributing to the modulation of the
inflammatory response during infection. Interestingly, significant
differences were observed between BtpA and BtpB. For exam-
ple, BtpA had an impact on TNF-α secretion (Salcedo et al.,
2008) but not BtpB, which affected surface expression of MHC
class II and co-stimulatory molecules that we had not previ-
ously seen with BtpA. These differences may be due to different
kinetics of translocation and time of action of each effector or
perhaps the kinetics of the cellular processes affected. These dif-
ferences could also be explained by specific targeting of host
pathways. Interestingly, translocation of VceC results in enhanced
pro-inflammatory responses as a result of the induction of the
unfolded protein response by this T4SS effector (de Jong et al.,
2012). This suggests that VirB effectors can have opposing effects,
resulting in either activation of host immune responses or spe-
cific inhibition of inflammatory pathways. These differences may
represent host cell or tissue specificity or simply reflect different
stages of disease. It is now crucial to undertake amore global anal-
ysis of the specific contribution of these effectors during infection
and a better characterization of host immune responses elicited in
vivo. It is also possible that some of the phenotypes observed with
effectors are simply an indirect or secondary effect of their action
on eukaryotic cells during infection. Defining at the molecular
level the effector cellular targets and analysing their contribution
during infection will hopefully shed some light on these issues.
The host interacting partner of BtpA remains controversial.
BtpA has been shown to induce degradation of phosphory-
lated TIRAP by enhancing its poly-ubiquitination (Sengupta
et al., 2010) and to efficiently block TIRAP-induced NF-κB
activation (Radhakrishnan et al., 2009). Together, these studies
present TIRAP as the main target of BtpA whereas other groups
have shown a direct interaction with MyD88 (Cirl et al., 2008;
Chaudhary et al., 2011). Although comparison of the ability of
BtpA to interact with TIRAP and MyD88 revealed a stronger
binding to MyD88 (Chaudhary et al., 2011), surprisingly this
interaction was dependent on the Death Domain of MyD88 and
not the TIR domain. By yeast-two hybrid we found that both
BtpA and BtpB can interact with MyD88. In the case of BtpB
this result could explain its ability to block TLRs that are depen-
dent on MyD88 signaling but not TLR3, which is dependent on
the adaptor TRIF. Although inhibition of TLR2 and TLR4 by
BtpA has been described, we did not detect any inhibition of
TLR9 (Salcedo et al., 2008), which would be expected if BtpA
was blocking MyD88. It is possible that inhibition of TLR9 by
BtpA requires higher levels of expression of BtpA and could not be
detected with our assay. Consistently, BtpA interfered with TLR5
signaling which is dependent on MyD88. Further work is now
required to understand the molecular mechanism by which BtpA
controls TLR activation, which may involve interaction and/or
competition with both MyD88 and TIRAP.
In addition to control of inflammatory responses, BtpA has
been shown to interact with phosphoinositides at the plasma
membrane and modulate microtubule dynamics (Radhakrishnan
et al., 2009, 2011). Ectopically expressed BtpA localizes to micro-
tubules. These could constitute important activities that may also
have a consequence on control of the inflammatory response,
for example by misplacing specific adaptor molecules within the
cell. In addition, these data indicate that BtpA may have addi-
tional eukaryotic targets yet to be identified. It will be interesting
to evaluate during infection the contribution of these different
functions of BtpA described in vitro and determine if they are
dependent on the TIR domain or if other domains are con-
tributing to assigning multiple functions to this effector. Our
results strongly implicate BtpB in the control of host inflamma-
tory responses during Brucella infection. However, it is possible
BtpB has additional functions as it has been described for BtpA.
We are currently determining if multiple pathways are targeted by
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BtpB to better understand the role of this novel effector during
Brucella infection.
MATERIALS AND METHODS
BACTERIAL STRAINS
The bacterial strains used in this study were S. enterica serovar
Typhimurium strain 12023, smooth virulent B. abortus strain
2308 (Pizarro-Cerdá et al., 1998) and the isogenicmutants virB9−
(Celli et al., 2005), virB10− (Sieira et al., 2000), btpA− (Salcedo
et al., 2008), btpB− (this study) and btpA− btpB− (this study). In
the case of Brucella, green fluorescent protein (GFP)-expressing
derivatives contain a pBBR1MCS-2 (Kovach et al., 1995) deriva-
tive expressing the gfp-mut3 gene under the control of the lac
promoter. Brucella strains were grown in tryptic soy broth (TSB;
Sigma-Aldrich) and Salmonella in Luria Bertani (LB) medium.
For infection, we inoculated 2ml of media for 16 h at 37◦C up
to an optical density (OD600 nm) of approximately 2.0 (Celli et al.,
2003). Salmonella strains were cultured 16 h at 37◦Cwith aeration
to obtain stationary phase cultures.
CONSTRUCTION OF btpB AND btpAbtpB MUTANTS
The btpB gene (BAB1_0756) was amplified from B. abortus
genomic DNA using primers 5’-acgcgacctttccggctccctt-3′ and
5′-ttcggctagacaggaatgcatg-3′ and ligated to pGem-T-Easy vector
(Promega) to generate pGem-TbtpB. The plasmid was linearized
with EcoRV. Linearized pGem-btpB was ligated to a fragment
containing a kanamycin resistance cassette to generate pGem-
TbtpB::Kan. This plasmid was electroporated into B. abortus 2308
where it is incapable of autonomous replication. Homologous
recombination events were selected using kanamycin resistance
(50μg/ml) and carbenicillin sensitivity (50μg/ml) in tryptic soy
agar plates. PCR and sequencing analyses showed that the btpB
wild type gene was replaced by the disrupted one. The mutant
strain obtained was called btpB−. btpAbtpB− double mutant was
obtained after electropration of pGem-TbtpB::Kan into btpA−
mutant (Salcedo et al., 2008). Homologous recombination events
were selected as previously described for btpB−single mutant.
PCR and sequencing analyses confirmed that btpA and btpB wild
type genes were replaced by the disrupted ones in the double
mutant strain.
CONSTRUCTION OF THE btpB COMPLEMENTED STRAIN
A DNA fragment coding for BtpB (325 aa) was amplified by
PCR using primers 5′-atggatccgtggcgaatgaaccaatccgc-3′ and 5′-
gcactagtctaggtgatgagggcgacgcg-3′ . The PCR product was inserted
by the flanking BamHI/SpeI sites (underlined) in the correspond-
ing sites of pBBR1 MCS-4 (Kovach et al., 1995). The integrity of
the construct was confirmed by sequence analysis. The plasmid
was introduced into btpB− mutant by biparental mating.
CONSTRUCTION OF TEM-1 AND CyaA FUSIONS
DNA fragments coding for VceC, VceA, BtpA (1-275), and
BtpB (1-292) were amplified by PCR, digested with XbaI
and PstI and cloned into pFlagTEM1 (Raffatellu et al., 2005).
Primers sequences with XbaI and PstI sites (underlined)
are: VceC-Fw: 5′-tcctctagagaacgttcagagcgtccagaa-3′ ; VceC-Rv:
5′-aaactgcagctaattgcgggtttctcccttg-3′ ; VceA-Fw: 5′-tcctctagaaaaat
catcatcacggcagca-3′; VceA-Rv: 5′-aaactgcagctagttcttgggcgcgtggcc-
3′; BtpA-Fw: 5′- tcctctagaagttcgtactcttctaatatt-3′ ; BtpA-Rv: 5′-
aaactgcagtcagataagggaatgcagttc-3′ ; BtpB-Fw: 5′- tcctctagatacaa
tttatttgtttcgggc-3′ ; BtpB-Rv: 5′- aaactgcagctaggtgatgagggcgacgcg-
3′. The integrity of all constructs was confirmed by sequence
analysis. Plasmids were introduced into B. abortus 2308 or
virB9/virB9− by electroporation. pFlagTEM1 encodes a copy of
TEM1 β-lactamase, in which the Sec-dependent signal sequence
has been deleted and replaced with a 3 × FLAG tag at the
N-terminus (Raffatellu et al., 2005). Expression of the fusion pro-
teins in Brucella was confirmed by Western blot using a mouse
anti-FLAG M2 antibody (Sigma-Aldrich). To generate plasmids
coding for fusions to the N-terminus of CyaA, BamHI/SpeI
DNA fragments coding for BtpA (1-275) and BtpB (1-292)
were obtained by PCR amplification with primers carrying
BamHI/SpeI sites and ligated into the corresponding sites of
pCyaA (Marchesini et al., 2011). Primers sequences with BamHI
and SpeI sites (underlined) are: BtpA-Fw: 5′-atggatccatgagttc
gtactcttctaata-3′ ; BtpA-Rv: 5′-ggactagtgataagggaatgcagttcttt-3′ ;
BtpB-Fw 5′- atggatccatgtacaatttatttgtttcgggc-3′ ; BtpB-Rv: 5′-
ggactagtggtgatgagggcgacgcgctc-3. To generate plasmids coding for
fusions to the C-terminus of CyaA, the genes coding for BtpA (1-
275) and BtpB (1-292) with flanking XbaI and SacII sites (under-
lined) were amplified using primers BtpA-Fw: 5′-tatctagaatgagttc
gtactcttctaatattg-3′/BtpA-Rv: 5′-tccccgcggtcagataagggaatgcagttc-
3′ and BtpB-Fw: 5′-tatctagaatgtacaatttatttgtttcgggct-3′ /BtpB-Rv:
5′-tccccgcggctaggtgatgagggcgacgcg-3′ . The DNA fragment cod-
ing for CyaA was amplified with flanking BamHI and SpeI sites
(underlined) using primers 5′-cgggatccatgcagcaatcgcatcaggct-3′
and 5′-cgactagtaaggctgtcatagccggaatcctggc-3′ . DNA fragments
coding for CyaA and BtpA or BtpB were ligated in the corre-
sponding sites of pDK51 under bcsp31 gene promoter as described
in (Marchesini et al., 2011). The integrity of all constructs was
confirmed by sequence analysis. Plasmids expressing CyaA fusion
proteins were introduced in B. abortus strains by biparental mat-
ing. Expression of the fusion proteins in Brucella was confirmed
by Western blot using a mouse serum raised against CyaA.
BACTERIAL INFECTION AND REPLICATION ASSAYS
BMDCs were prepared from 6-8 week-old female C57BL/6 mice
(Lelouard et al., 2002). Infections were performed at a multiplic-
ity of infection of 30:1. Bacteria were centrifuged onto BMDCs at
400 g for 10min at 4◦C and then incubated for 30min at 37◦C
with 5% CO2 atmosphere. Cells were gently washed twice with
medium and then incubated for 1 h in medium supplemented
with 100μg/ml streptomycin to kill extracellular bacteria (or gen-
tamicin for Salmonella). Thereafter, the antibiotic concentration
was decreased to 20μg/ml. Control samples were always per-
formed by incubating cells with media only and following the
exact same procedure for infection. To monitor bacterial intra-
cellular survival, infected cells were lysed with 0.1% Triton X-100
in H2O and serial dilutions plated onto TSB agar to enumerated
CFUs.
IMMUNOFLUORESCENCEMICROSCOPY NF-kB
Cells were fixed in 3% paraformaldehyde, pH 7.4, at room tem-
perature for 20min. Cells were then permeabilized for 10min
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with 0.1% saponin in PBS, followed by a blocking for 1 h with
2% BSA in PBS. Primary antibodies were incubated for 1 h
followed by 3 washes in PBS, 1 h incubation for secondary anti-
bodies, 2 washes in PBS and 1 wash in water before mount-
ing with Prolong Gold (Life technologies). Primary antibod-
ies used: rabbit anti-p65 from Santa Cruz at 1/250, hamster
anti-CD11c from BioLegend at 1/100 and cow anti-Brucella
LPS antibody at 1/2000. Secondary antibodies used: goat anti-
hamster Alexa 594, donkey anti-rabbit Cy3, goat anti-cow FITC,
all from Jackson Immunoresearch. Nuclei were stained with
TOPRO-3.
Samples were examined on a Leica SP5 laser scanning confocal
microscope for image acquisition. Images of 1024 × 1024 pixels
were then assembled using Adobe Photoshop 7.0. In all exper-
iments we used an anti-CD11c antibody confirming analysis of
DCs only. Quantification was always done by counting at least
100 cells in 4 independent experiments, for a total of at least 400
host cells analysed.
FLOW CYTOMETRY OF INFECTED CELLS
BMDCs were harvested 8 h or 24 h after infection and stained
for 20min at 4◦C with anti CD11c APC-Cy7, anti CD40 Alexa
647, anti CD80 Pe-Cy5, anti CD86 FITC and anti MHC class
II PE (all purchased at BioLegend). Cells were then washed
once in 1% FCS in PBS and once in PBS. Cells were fixed for
20min in 3% PFA at room temperature. At least 100,000 CD11c+
events were collected on flow cytometry using a FACS Canto II
(Becton Dickinson) and analysis was done on FlowJo software
(TreeStar).
TEM TRANSLOCATION ASSAY
RAW cells were seeded in a 96 well plates at 1 × 104 cells/well
overnight. Cells were then infected with an MOI of 500:1 by cen-
trifugation at 4◦C, 400 g for 5min and 20min at 37◦C 5% CO2.
Cells were then washed twice with DMEM and 200μl of com-
plete media, with gentamicin (50μg/ml) and 1mM of IPTG was
added for 1 h. Media was replaced by 200μl of complete DMEM,
with gentamicin (10μg/ml) and 1mM of IPTG. At 4 or 24 h after
infection cells were washed with 100μl HBSS. 20μl of CFF2 mix
(as described by Life Technologies protocol) was then added to
each well, and plate incubated for 1.5 h at room temperature in
the dark. Cells were finally washed with 100μl PBS and analysed
immediately by microscopy. A total of 5000 cells were counted
from 5 independent experiments in an automated manner using
imageJ.
CyaA ASSAYS
Translocation of BtpA and BtpB into host cells was assayed using
the CyaA fusion approach. After infection of J774.A1 cells (MOI
250:1) for 4 h in 96-wells plates (105 cells/well), cells were gently
washed five times with PBS and lysed. Intracellular cAMP lev-
els were determined by Direct cAMP Enzyme Immunoassay Kit
(Sigma, CA200) as described by the manufacturer.
CYTOKINEMEASUREMENT
Sandwich enzyme-linked immunosorbent assays (ELISA) from
ebioscience were used to detect IL-12 (p40/p70) and TNFα
from supernatants of BMDCs infected with different Brucella
strains.
LUCIFERASE ACTIVITY ASSAY
HEK 293 T cells were transiently transfected using Fugene
(Roche) for 24 h, according to manufacturer’s instructions, for
a total of 0.4μg of DNA consisting of 50 ng TLR plasmids,
200 ng of pBIIXLuc reporter plasmid, 5 ng of control Renilla
luciferase (pRL-null, Promega) and 50 ng of myc-BtpA or myc-
BtpB expression vectors. The total amount of DNA was kept
constant by adding empty vector. Where indicated, cells were
treated with E. coli LPS (1μg/ml), Pam2CSK4 (100 ng/ml),
CpG ODN1826 (1μM), Flagellin Fl-ST (1μg/ml) and poly(I:C)
(25μg/ml), all obtained from Invivogen, for 6 h and then cells
were lysed and luciferase activity measured using Dual-Glo
Luciferase Assay System (Promega). The BtpB constructs were
obtained by cloning in the gateway (Life Technologies) entry vec-
tor and then cloned in pMyc. The following primers were used
for BtpB (178 aa) ggggacaagtttgtacaaaaaagcaggcttcatgaatcgtacgca
ctgggcg and as reverse primer ggggaccactttgtacaagaaagctgggtcc
taggtgatgagggcgacgcg. For BtpB (1-292) the forward primer was
ggggacaagtttgtacaaaaaagcaggcttctacaatttatttgtttcgggc. The BtpA
(1-275) primers were: ggggacaagtttgtacaaaaaagcaggcttcatgagttcgta
ctcttctaatatt and the reverse primer was ggggaccactttgtacaagaaa
gctgggtctcagataagggaatgcagttc.
YEAST TWO-HYBRID ASSAY
The plasmids used for the Y2H interaction test were obtained by
using the Gateway™ technique, except the pACT2 vector encod-
ing humanMyD88-Gal4 activation domain (AD) fusion that was
provided by L. O’Neill. Briefly, human MyD88 and B. melitensis
16M BtpA (BMEI1674) were amplified by PCR respectively
from the pACT2-MyD88 vector and from genomic DNA with
Gateway™ primers (GWMyD88F and GWMyD88R; GWbtpAF
and GWbtpAR). PCR products were then separately cloned
into the entry vector pDONR201 (Invitrogen Life-technologies)
as previously described (Dricot et al., 2004). For btpB, the
corresponding entry vector pDONR201-BMEI1216 from the
ORFeome was used (Dricot et al., 2004). LR reactions were then
performed as recommended by the manufacturer (Invitrogen
Life-technologies) in order to clone MyD88 into pVV212 (Van
Mullem et al., 2003) downstream of the Gal4 DNA-binding
domain (BD), and BtpA and BtpB into pVV213 (Van Mullem
et al., 2003) downstream of the Gal4 AD. Haploïd Saccharomyces
cerevisiae strains Mav103 andMav203 (Walhout and Vidal, 2001)
were transformed with BD and AD fusion protein vectors respec-
tively. Diploid yeasts carrying both plasmids were obtained by
mating and selected on synthetic dextrose medium (SD) lacking
leucine (leu) and tryptophan (trp) as previously described (Hallez
et al., 2007). Protein interactions were assessed on medium lack-
ing histidine (his) supplemented with 20mM triaminotriazole
(3AT). The β-galactosidase expression filter assay using the
LacZ reporter gene was performed as described previously
(Dozot et al., 2010). The primers used for two-hybrid constructs
were: GWMyD88Fggggacaagtttgtacaaaaaagcaggctcgcgatggctgcagg
aggtcccg ;GWMyD88Rggggaccactttgtacaagaaagctgggtaagggcaggga
caaggccttg ;GWbtpAFggggacaagtttgtacaaaaaagcaggctcgatgagttcgta
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ctcttctaat ;GWbtpARggggaccactttgtacaagaaagctgggtagataagggaatg
cagttc.
MOUSE INFECTION STUDIES
Groups of 7- to 9-week-old female IRF 1−/− or BALB/c mice were
intraperitoneally inoculated with 106 CFU of B. abortus strains
in 0.2ml PBS. The infected mice were housed in cages within a
biosafety level 3 facility and IRF 1−/− mice were monitored daily
for survival. At the indicated times post-infection, spleens from
infected mice were removed and homogenized in 2ml of PBS.
Tissue homogenates were serially diluted and plated in duplicate
on TSA with the appropriate antibiotic. CFU were counted after
3–4 days of incubation at 37◦C.
HISTOLOGICAL AND IMMUNOHISTOLOGICAL ANALYSIS
For each mouse, the spleen was removed, fixed with buffered
formalin 4%, and embedded in paraffin. Serial sections (3μm)
of these specimens were obtained for routine hematoxylin-eosin
and immunohistochemical investigations to assess the presence of
granulomas and bacterial antigens, respectively.
Granulomas were defined as collections of ten or more
macrophages within the organs. The inflammatory granulomas
present in each tissue section of the spleens were counted dur-
ing microscopic examination, and the total area of tissue sections
was determined by quantitative image analysis as described previ-
ously (Stein et al., 2005). The results were expressed as the number
of granulomas found per surface unit (i.e., square centimeters).
Counts of granulomas were expressed as the mean ± the stan-
dard deviation per square centimeter and compared by using
the Student t test. Immunohistochemical analysis was performed
with a rabbit anti-B. abortus antibody used at a 1:1000 dilution
with hemalun counterstain. The immunohistological procedure,
in which an immunoperoxidase kit was used, has been described
elsewhere (Leone et al., 2004). For each section, a negative control
was performed with normal rabbit serum.
STATISTICAL ANALYSIS
Unpaired two-tailed Student’s t test was carried out to deter-
mine the statistical differences between experimental data sets.
P ≥ 0.05 were not considered significant; P ≤ 0.001 are denoted
with ∗ ∗ ∗; P ≤ 0.01 are denoted with ∗∗ and P between 0.01 and
0.05 are denoted with ∗. Statistical differences between IRF-1 −/−
mice survival curves were determined with Mantel-Cox test.
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